| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/08/2009 | US20090252705 IL-6/IL-6R Fusion Protein |
| 10/08/2009 | CA2720178A1 Method of treating genetic disorders |
| 10/08/2009 | CA2719963A1 Double-stranded lipid-modified rna having high rna interference effect |
| 10/07/2009 | EP2107109A1 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 10/07/2009 | EP2106807A1 Compositions and kits for enhancing delivery of therapeutic agents to cells |
| 10/07/2009 | EP1617216B1 Novel method of screening |
| 10/07/2009 | EP1187917B1 Cd44 splice variant associated with rheumatoid arthritis |
| 10/07/2009 | EP0907735B2 Modulators of tissue regeneration |
| 10/07/2009 | EP0907730B1 Haemopoietin receptor and genetic sequences encoding same |
| 10/07/2009 | CN101553567A Method for inhibiting or treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 10/07/2009 | CN101550416A Humanized single anti-Hu-ScFv18 light and heavy chain variable region gene and coding polypeptide thereof and application thereof |
| 10/07/2009 | CN101550415A Analogue of micro RNA-181a precursor and uses thereof |
| 10/07/2009 | CN101550189A Anthropogenic antivirulin glycosidoprotein neutralizing genetic engineering antibody RD9 and preparation and application thereof |
| 10/07/2009 | CN101550185A New tumor-related gene or protein and application thereof |
| 10/07/2009 | CN101549153A Composite and method for self-treating tumor |
| 10/07/2009 | CN100547075C Her-2/neu DNA vaccine having anti-cancer activity |
| 10/07/2009 | CN100547074C Reconstruction of HIV-1 Chinese epidemic strain gag gene and recombination DNA vaccine thereof |
| 10/07/2009 | CN100547071C Antisense antiviral agent and method for treating ssRNA viral infection |
| 10/07/2009 | CN100546657C Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 10/07/2009 | CN100546654C Use of chitosan quaternary ammonium salt/rectorite nano composite material |
| 10/06/2009 | USRE40930 Porcine adenovirus type 3 genome |
| 10/06/2009 | US7598421 Lipids such as 2,3-Di-[(Z)-octadec-9-enyloxy]-propyl}-N-(2-{2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethoxy}-ethyl)-N,N-dimethylammonium bromide; integrin-binding peptides |
| 10/06/2009 | US7598362 Hepatitis C virus vaccine |
| 10/06/2009 | US7598228 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death |
| 10/06/2009 | US7598225 Generation of immune response to prostate-specific antigen (PSA) |
| 10/06/2009 | US7598078 Deliver a heterologous nucleic acid sequence in prime-boost vaccination regimens; sequence encodes the same gene product or antigen in the recombinant adenovirus vector of the first and second serotype; viral antigens are Ebola, measles, West Nile, HIV, SIV; cross neutralization not an issue |
| 10/06/2009 | US7598077 Compositions and methods for enhancing differential expression |
| 10/06/2009 | US7598070 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 10/06/2009 | US7598059 Neublastin expression constructs |
| 10/06/2009 | US7598048 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions |
| 10/06/2009 | US7598045 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer |
| 10/06/2009 | US7598042 Early prostate cancer antigens (EPCA), polynucleotide sequences encoding them, and their use |
| 10/06/2009 | US7597905 Hollow nanoparticle for use in the transfer of biopolymer into cells |
| 10/06/2009 | US7597889 Recombinant polypeptides and nucleic acids; Graft-vs-host disease, host-vs-graft disease, organ transplant rejection, bone-marrow transplant rejection, autoimmune vasculitis, arthritis or asthma |
| 10/06/2009 | US7597886 Tumor necrosis factor-gamma |
| 10/06/2009 | CA2442284C Biodegradable carrier and method for preparation thereof |
| 10/06/2009 | CA2381348C Lck-derived peptides activating ctls |
| 10/06/2009 | CA2356960C Compositions and methods for intraductal gene therapy |
| 10/06/2009 | CA2284689C Animal model for evaluation of vaccines |
| 10/04/2009 | CA2625304A1 Androgen receptor related methods for treating bladder cancer |
| 10/01/2009 | WO2009120978A2 Treatment of metabolic-related disorders using hypothalamic gene transfer of bdnf and compositions therfor |
| 10/01/2009 | WO2009120801A2 Ikki inhibitor therapies and screening methods, and related ikki diagnostics |
| 10/01/2009 | WO2009120741A2 Inhibition of trim62 activity reduces cancer cell proliferation |
| 10/01/2009 | WO2009120712A2 Compositions and methods for diagnosing and treating melanoma |
| 10/01/2009 | WO2009120371A2 Computationally designed inhibitors of amyloidosis |
| 10/01/2009 | WO2009120247A2 Lipid nanoparticle compositions and methods of making and using the same |
| 10/01/2009 | WO2009119874A1 Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity |
| 10/01/2009 | WO2009119836A1 Composition for external application comprising transcription factor decoy as active ingredient |
| 10/01/2009 | WO2009119794A1 Prophylactic/therapeutic agent for infectious disease |
| 10/01/2009 | WO2009119793A1 Method for production of transfected cell |
| 10/01/2009 | WO2009119499A1 Stent |
| 10/01/2009 | WO2009118259A1 Ptph1 inhibitors for the treatment of alzheimer's disease |
| 10/01/2009 | WO2009118204A2 Medicament, compositions, and substances for treating and identifying adenocarcinoma of the lung |
| 10/01/2009 | WO2009090330A3 Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections |
| 10/01/2009 | WO2009044383A8 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof |
| 10/01/2009 | WO2009024834A8 Nucleic acids involved in viral infection |
| 10/01/2009 | WO2008051306A8 Soluble tnf receptors and their use in treatment of disease |
| 10/01/2009 | WO2008017636A8 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 10/01/2009 | WO2005067620A9 ANTIBODIES TO MAdCAM |
| 10/01/2009 | US20090249502 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; antibody or antigen-binding fragment thereof that specifically binds to a 193P1E1B protein; drug delivery |
| 10/01/2009 | US20090249500 System for monitoring bacterial tumor treatment |
| 10/01/2009 | US20090247733 Novel Bone Mineralization Proteins, DNA, Vectors, Expression Systems |
| 10/01/2009 | US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease |
| 10/01/2009 | US20090247610 Integrase cofactor |
| 10/01/2009 | US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 10/01/2009 | US20090247482 50 Human Secreted Proteins |
| 10/01/2009 | US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 10/01/2009 | US20090246854 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 10/01/2009 | US20090246830 Recombinant influenza viruses for vaccines and gene therapy |
| 10/01/2009 | US20090246827 Recombinant toxin fragments |
| 10/01/2009 | US20090246272 Mda-7 proteins and methods of use thereof |
| 10/01/2009 | US20090246219 NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE) |
| 10/01/2009 | US20090246201 Substances |
| 10/01/2009 | US20090246189 Methods for Promoting Neurite Outgrowth and Survival of Dopaminergic Neurons |
| 10/01/2009 | US20090246183 eNOS mutations useful for gene therapy and therapeutic screening |
| 10/01/2009 | US20090246182 Method for culturing cells derived from the adipose tissue and uses thereof |
| 10/01/2009 | US20090246180 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 10/01/2009 | CA2756731A1 Compositions and methods for diagnosing and treating melanoma |
| 10/01/2009 | CA2719247A1 Ikki inhibitor therapies and screening methods, and related ikki diagnostics |
| 10/01/2009 | CA2718731A1 Recombinant rhinovirus vectors |
| 10/01/2009 | CA2718093A1 Ptph1 inhibitors for the treatment of alzheimer's disease |
| 09/30/2009 | EP2105511A1 Medicament compositions and substances for treatment and identifying adenocarcinoma of the lung |
| 09/30/2009 | EP2105504A2 Genes and proteins, and their use |
| 09/30/2009 | EP2104516A2 Methods and compositions related to the structure and function of apobec3g |
| 09/30/2009 | EP1739186B1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor |
| 09/30/2009 | EP1693378B1 Protein nmb1125 and use thereof in pharmaceutical formulations |
| 09/30/2009 | EP1287153B1 Methods and compositions for efficient gene transfer using transcomplementary vectors |
| 09/30/2009 | EP1185655B1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 09/30/2009 | CN101543625A Use of CENP-E binding protein and its coding gene in preparing medicine for suppressing tumor proliferation |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN100545174C Compositions and methods for wt1 specific immunotherapy |
| 09/29/2009 | US7595431 Mouse models of human prostate cancer |
| 09/29/2009 | US7595411 Transferring drugs; antitumor agents, anticancer agents |
| 09/29/2009 | US7595389 siRNA targeting casitas B cell lymphoma-B (CBL-B) |
| 09/29/2009 | US7595376 Poly zinc finger proteins with improved linkers |
| 09/29/2009 | US7595306 Method of treating neurodegenerative disease |
| 09/29/2009 | US7595305 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 09/29/2009 | US7595303 Genetic adjuvants for immunotherapy |
| 09/29/2009 | US7595301 Staple type oligonucleotide and drug comprising the same |
| 09/29/2009 | US7595058 Chlamydia antigens and vaccine uses of the protein |